Skip to content

Released Aug 14, 2012, during market hours

10-Q filed Aug 14, 2012, 45 days after period end · 0001144204-12-045521

Q2 2012 · 10-Q
Revenue—
Net Income-$6.30KN/M vs Q2 2011N/M vs Q1 2012
EPS Diluted$0.00— vs Q2 2011no prior Q1 2012 on file
Operating Income-$5,031N/M
Operating Cash Flowderived-$14,287N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2012Q2 2011Q2 2010
Net Income-$6.30K-$6.76K-$5.58K
EPS Diluted$0.00$0.00$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR